Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMCT
4126
Creative Media & Community Trust
CMCT
$13M
| $92.4K | ﹤0.01% |
8
+1
| +14% | +$50.4K |
|
4127
TOMI Environmental Solutions
TOMZ
$14M
| $92.3K | ﹤0.01% |
38,804
+2,004
| +5% | +$4.76K |
|
|
AMRN
4128
Amarin Corp
AMRN
$303M
| $92.2K | ﹤0.01% |
7,351
-3,827
| -34% | -$50.8K |
|
4129
Retractable Technologies
RVP
$20.1M
| $91.8K | ﹤0.01% |
119,166
-15,056
| -11% | -$15.1K |
|
4130
Barnwell Industries
BRN
$14.1M
| $91.5K | ﹤0.01% |
40,490
-591
| -1% | -$1.35K |
|
|
BCG
4131
Binah Capital Group
BCG
$22.7M
| $91.5K | ﹤0.01% |
29,992
+8,418
| +39% | +$33.4K |
|
4132
Compugen
CGEN
$228M
| $91.2K | ﹤0.01% |
50,395
| – | – |
|
4133
Indaptus Therapeutics
INDP
$157M
| $90.7K | ﹤0.01% |
2,612
+494
| +23% | +$24.2K |
|
|
MESO
4134
Mesoblast
MESO
$2.07B
| $90.1K | ﹤0.01% |
+11,025
| New | +$74.8K |
|
4135
ClearOne Inc
CLRO
$27.2M
| $89.8K | ﹤0.01% |
9,664
+1,375
| +17% | +$13.1K |
|
4136
Splash Beverage Group
SBEV
$2.72M
| $88.9K | ﹤0.01% |
2,205
+566
| +35% | +$28.5K |
|
4137
IN8bio
INAB
$9.64M
| $88.9K | ﹤0.01% |
10,976
+397
| +4% | +$7.19K |
|
4138
Estrella Immunopharma
ESLA
$31.1M
| $88.8K | ﹤0.01% |
76,556
+18,342
| +32% | +$23.6K |
|
4139
Similarweb
SMWB
$658M
| $88.6K | ﹤0.01% |
+10,022
| New | +$79.2K |
|
4140
Dolphin Entertainment
DLPN
$14.3M
| $88.2K | ﹤0.01% |
69,992
+10,488
| +18% | +$15.9K |
|
|
CBIO
4141
Crescent Biopharma
CBIO
$626M
| $88.1K | ﹤0.01% |
5,212
+340
| +7% | +$7.13K |
|
4142
Smith Micro Software
SMSI
$16.2M
| $88K | ﹤0.01% |
17,260
+341
| +2% | +$2.4K |
|
4143
American Shared Hospital Services
AMS
$9.87M
| $87.8K | ﹤0.01% |
28,783
+2,880
| +11% | +$8.93K |
|
4144
Cyclerion Therapeutics
CYCN
$16.7M
| $87.5K | ﹤0.01% |
33,908
-70
| -0.2% | -$206 |
|
4145
Martin Midstream Partners
MMLP
$95.9M
| $87.3K | ﹤0.01% |
23,928
-9,140
| -28% | -$32.9K |
|
4146
Codere Online
CDRO
$408M
| $86.9K | ﹤0.01% |
+10,877
| New | +$86.2K |
|
|
HURA
4147
TuHURA Biosciences
HURA
$136M
| $86.7K | ﹤0.01% |
12,698
+2,872
| +29% | +$21.4K |
|
|
ATIP
4148
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $86.1K | ﹤0.01% |
14,107
| – | – |
|
4149
Rocky Mountain Chocolate Factory
RMCF
$7.84M
| $85.1K | ﹤0.01% |
42,519
+6,114
| +17% | +$11.5K |
|
4150
Alpha Tau Medical
DRTS
$1.19B
| $85K | ﹤0.01% |
35,716
| – | – |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.